Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 1, 2011, Pages 10-14

  Pereira, Telma C ^a,b   Share, Sarah M ^a,b   Magalhães, Albino V ^a,b   Silverman, Jan F ^a,b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

immunohistochemistry; microarray; Squamous cell carcinoma

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; K903 PROTEIN; NAPSIN A; PROTEIN P16; PROTEIN P63; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER; UNCLASSIFIED DRUG; VILLIN;

ANUS; ARTICLE; BLADDER; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; CONTROLLED STUDY; ESOPHAGUS; FEMALE; HEAD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG; MALE; METASTASIS; NECK; PENIS; PRIORITY JOURNAL; RECTUM; SKIN; SQUAMOUS CELL CARCINOMA; THYROID GLAND; TISSUE MICROARRAY; TONGUE; URETHRA; UTERINE CERVIX; VAGINA; VULVA;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; ORGAN SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 78650804445     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181ecaf1c     Document Type: Article

References (29)

1. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol. 2002;10:97-102.
2. Nakamura N, Miyagi E, Murata S, et al. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol. 2002;15:1058-1067.
3. Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med. 2008;132:326-348.
4. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med. 2008;132:384-396.
5. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41:20-25.
6. Suzuki A, Shijubo N, Yamada G, et al. Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract. 2005;201:579-586.
7. Kobayashi M, Ueyama Y, Nakanishi H, et al. Immunocytochemical detection using CDX2: An aid for discerning tumor involvement in ascites cytology. Cancer. 2006;108:114-118.
8. Shi XY, Bhagwandeen B, Leong AS. CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus. Am J Clin Pathol. 2008;129:571-577.
9. Mittal K, Soslow R, McCluggage WG. Application of immunohistochemistry to gynecologic pathology. Arch Pathol Lab Med. 2008;132:402-423.
10. Yildiz IZ, Usubütün A, Firat P, et al. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Pathol Res Pract. 2007;203:445-449.
11. Santos MN, Landolfi S, Olivella A, et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol. 2006;30:1347-1356.
12. Nemes JA, Deli L, Nemes Z, et al. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endod. 2006;102:344-352.
13. Smith EM, Wang D, Kim Y, et al. P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol. 2008;44:133-142. (Pubitemid 351179656)
14. Karsai S, Abel U, Roesch-Ely M, et al. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol. 2007;211:314-322.
15. O'Regan EM, Toner ME, Finn SP, et al. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol. 2008;39:452-458.
16. Laco J, Slaninka I, Jirá sek M, et al. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions. Pathol Res Pract. 2008;204:545-552.
17. Rossi G, Marchioni A, Milani M, et al. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol. 2004;122: 884-893.
18. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
19. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol. 2002;15:6-10.
20. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
21. Oien KA. Pathologic evaluation of unknown primary cancer. Semin Oncol. 2009;36:8-37.
22. Greco FA, Hainsworth JD. Introduction: unknown primary cancer. Semin Oncol. 2009;36:6-7.
23. Ghosh L, Dahut W, Kakar S, et al. Management of patients with metastatic cancer of unknown primary. Curr Probl Surg. 2005;42: 12-66.
24. Varadhachary GR, Greco FA. Overview of patient management and future directions in unknown primary carcinoma. Semin Oncol. 2009;36:75-80.
25. Hainsworth JD, Fizazi K. Treatment for patients with unknown primary cancer and favorable prognostic factors. Semin Oncol. 2009;36:44-51.
26. Culine S. Prognostic factors in unknown primary cancer. Semin Oncol. 2009;36:60-64.
27. Waltonen JD, Ozer E, Hall NC, et al. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg. 2009;135: 1024-1029.
28. Hobbs CG, Sterne JA, Bailey M, et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31:259-266.
29. Zhang MQ, El-Mofty SK, Davila RM. Detection of human papillomavirus- related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer. 2008;114:118-123.